Biologic Implant Regrows Cartilage and Bone
By HospiMedica International staff writers Posted on 19 Mar 2019 |

Image: A novel implant regenerates true hyaline cartilage and bone (Photo courtesy of CartiHeal).
A novel cell-free biomaterial implant repairs cartilage and osteochondral defects in both traumatic and osteoarthritic joints.
The CartiHeal (Kfar Saba, Israel) Agili-C implant is designed to provide a scaffold that reproducibly regenerates hyaline cartilage and its underlying subchondral bone in a single-step procedure. Once the size of the defect is determined, a cavity is prepared in the affected area and the implant is inserted in a press fit manner. Blood immediately infiltrates the implant’s interconnected pores, initiating a biological cascade culminating in bone and hyaline cartilage regeneration through migration, adhesion, proliferation, and differentiation of mesenchymal stem cells (MSCs).
Within a few months, the top layer turns into true hyaline cartilage, while the bottom layer turns to bone, with each tissue genetically identical to the body’s own tissues. The regenerated cells gradually biodegrade the implanted scaffold over time. The rigid, bi-phasic implant is made of biocompatible and biodegradable aragonite, a naturally occurring crystal form of calcium carbonate (CaCO3) that forms the backbone of coral. The bone phase of the implant is composed of CaCO3 in crystalline form, and the cartilage phase is a composite of modified aragonite and hyaluronic acid (HA).
“Cartilage has very limited ability to be repaired. Finding a solution for cartilage regeneration is one of the holy grails of medicine. Millions of patients are looking for a solution to the degeneration of knee cartilage. We hope we can provide a breakthrough with our technology,” said Nir Altschuler, CEO and founder of CartiHeal. “Cartilage and bone cells adhere to the implant, while at the same time gradually degrading the calcium from the scaffold. Eventually the implant is almost fully degraded as bone and cartilage regrow.”
“As orthopedic surgeons, our goal is to prevent further erosion or cartilage damage within the knee, by promoting the growth of healthy cartilage,” said Guy Morag, MD, director of the sports medicine unit at Sourasky Medical Center (Tel Aviv, Israel), who is participating in CartiHeal's pivotal U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) study. “The Agili-C implant leads to formation of high quality articular cartilage as well as underlying subchondral bone, which we haven't been able to achieve with other available modalities.”
CaCO3 is a common substance found in sedimentary rocks in mineral form, such as calcite and aragonite, most notably as limestone. It is also the main component in the shells of marine organisms, snails, and eggs. Marine CaCO3 skeletons, such as coral, have an architecture that gives them structural support and other functions. For example, seashells have dense lamellar structures, while coral, cuttlebone, and sea urchin spines have interconnected porous structures.
Related Links:
CartiHeal
Sourasky Medical Center
The CartiHeal (Kfar Saba, Israel) Agili-C implant is designed to provide a scaffold that reproducibly regenerates hyaline cartilage and its underlying subchondral bone in a single-step procedure. Once the size of the defect is determined, a cavity is prepared in the affected area and the implant is inserted in a press fit manner. Blood immediately infiltrates the implant’s interconnected pores, initiating a biological cascade culminating in bone and hyaline cartilage regeneration through migration, adhesion, proliferation, and differentiation of mesenchymal stem cells (MSCs).
Within a few months, the top layer turns into true hyaline cartilage, while the bottom layer turns to bone, with each tissue genetically identical to the body’s own tissues. The regenerated cells gradually biodegrade the implanted scaffold over time. The rigid, bi-phasic implant is made of biocompatible and biodegradable aragonite, a naturally occurring crystal form of calcium carbonate (CaCO3) that forms the backbone of coral. The bone phase of the implant is composed of CaCO3 in crystalline form, and the cartilage phase is a composite of modified aragonite and hyaluronic acid (HA).
“Cartilage has very limited ability to be repaired. Finding a solution for cartilage regeneration is one of the holy grails of medicine. Millions of patients are looking for a solution to the degeneration of knee cartilage. We hope we can provide a breakthrough with our technology,” said Nir Altschuler, CEO and founder of CartiHeal. “Cartilage and bone cells adhere to the implant, while at the same time gradually degrading the calcium from the scaffold. Eventually the implant is almost fully degraded as bone and cartilage regrow.”
“As orthopedic surgeons, our goal is to prevent further erosion or cartilage damage within the knee, by promoting the growth of healthy cartilage,” said Guy Morag, MD, director of the sports medicine unit at Sourasky Medical Center (Tel Aviv, Israel), who is participating in CartiHeal's pivotal U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) study. “The Agili-C implant leads to formation of high quality articular cartilage as well as underlying subchondral bone, which we haven't been able to achieve with other available modalities.”
CaCO3 is a common substance found in sedimentary rocks in mineral form, such as calcite and aragonite, most notably as limestone. It is also the main component in the shells of marine organisms, snails, and eggs. Marine CaCO3 skeletons, such as coral, have an architecture that gives them structural support and other functions. For example, seashells have dense lamellar structures, while coral, cuttlebone, and sea urchin spines have interconnected porous structures.
Related Links:
CartiHeal
Sourasky Medical Center
Latest Surgical Techniques News
- Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
- Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
- Spectroscopy Technique Improves Surgery for Pediatric Epilepsy Patients
- Bioengineered Arteries Show Promise for Cardiovascular Surgery
- Online Tool Guides Surgical Decisions for Gallbladder Cancer
- Innovative Technology Enables Rapid Life-Saving Surgical Leak Detection
- First-Of-Its-Kind Bioresorbable Implant to Help Children with Rare Respiratory Disease
- Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots
- "Ultra-Rapid" Testing in the OR Could Enable Accurate Removal of Brain Tumors
- Automated Endoscopic Device Obtains Improved Biopsy Results in Single Pass
- World's First Machine Learning Model Combats Wrong-Site Surgery
- Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk
- New Surface Coating Could Prevent Blood Clotting in Medical Devices and Implants
- Dumbbell-Shaped Thrombectomy Device Offers Novel Approach to Cerebral Venous Sinus Thrombosis Treatment
- Novel Catheter Mimics Snake Teeth to Grab Blood Clots
- New Laparoscopic Imaging Technique Accurately Maps Biological Tissue for Minimally Invasive Surgery
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more